- Title: Subtitle
- Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma
- Creators
- G. Hu - Mayo ClinicS. Dasari - Mayo Clinic in FloridaYw AsmannPt GreippRa KnudsonHk BensonY. Li - Mayo ClinicBw EckloffJin Jen - Mayo ClinicBk LinkL. Jiang - Department of Laboratory Medicine and Pathology Mayo Clinic Jacksonville FL USAJs SidhuLe WellikTe Witzig - Mayo Clinic in FloridaNn BennaniJr CerhanRl BoddickerAl Feldman
- Resource Type
- Letter/Communication
- Publication Details
- Leukemia, Vol.32(2), pp.565-569
- DOI
- 10.1038/leu.2017.309
- PMID
- 29026208
- PMCID
- PMC5803446
- NLM abbreviation
- Leukemia
- ISSN
- 0887-6924
- eISSN
- 1476-5551
- Grant note
- 5UL1TR000135-08 / National Institutes of Health (nih_________::NIH) 2P50CA097274-06 / National Institutes of Health (nih_________::NIH) 5R01CA177734-03 / National Institutes of Health (nih_________::NIH) 5P30CA015083-32 / National Institutes of Health (nih_________::NIH)
- Language
- English
- Date published
- 10/01/2017
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984359950502771
Letter/Communication
Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma
Leukemia, Vol.32(2), pp.565-569
10/01/2017
DOI: 10.1038/leu.2017.309
PMCID: PMC5803446
PMID: 29026208
Abstract
Details
Metrics
7 Record Views